Isoray Unveils New Facility, Plans to Add Jobs
RICHLAND, Wash.- Isoray Medical of Richland announced plans Thursday to double their workforce in the coming months.
This comes at the same time as the opening of their new manufacturing facility in Richland.
With it, Isoray plans on pumping out more than 100,000 cancer treatment seeds a month when production gets going.
They're calling it a building within a building.
Isoray Medical unveiled their new shop in Richland, and with it, plans to up employment from 70 to around 150.
"It'll more than double the size of the company because we can run approximately 100,000 seeds through here a month that's with the way we're set up right now," said company Chairman and CEO Roger Girard.
Isoray makes the Cesium-131 seed, a revolutionary prostate cancer treatment. And with the new building, they'll up production.
"We're getting a lot of buzz at professional society meetings, a lot of docs are starting to adopt," said Dale Boyce, an employee.
According to the CEO, expansion won't stop there.
The small Richland based company plans on opening another plant in Russia next year, then Europe and one in Pocatello, Idaho.
"Cesium is an amazing isotope with it's high energy, short half-life and particularly we have 510-k, in other words FDA approval to market for all malignant soft tissue," said Girard.
Building within the already existing APEL building saved more than $10 million in construction costs. That's why they're calling it a building within a building.
The company plans on starting full production by the 15th of September and adding those new jobs sometime around the end of the year.